Literature DB >> 12465088

Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein.

Blas Morales1, Armando Martínez, Isabel Gonzalo, Lidice Vidal, Raquel Ros, Estrella Gomez-Tortosa, Alberto Rabano, Israel Ampuero, Marina Sánchez, Janet Hoenicka, Justo García De Yébenes.   

Abstract

Steele-Richardson-Olszewski syndrome (SROS) is a neurodegenerative disorder of unknown aetiology, most frequently sporadic. Familial cases of SROS have been described. An intronic polymorphism of the tau gene is associated with sporadic SROS and mutations of the tau gene are present in atypical cases of SROS. The role of tau has been excluded in other families with pathology proven SROS, suggesting that this syndrome may have multiple causes. An 82-year-old patient, father of 3 children with autosomal recessive juvenile parkinsonism due to combined heterozygous mutations of the parkin gene, developed clinical features of SROS 2 years before death. The diagnosis was confirmed by pathology. He carried the C212Y mutation of the parkin gene and was homozygous for the A0 polymorphism and for the H1 haplotype. The role of parkin in the processing of tau is discussed. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12465088     DOI: 10.1002/mds.10264

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

1.  The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Authors:  Alexander Zimprich; Bertram Müller-Myhsok; Matthew Farrer; Petra Leitner; Manu Sharma; Mary Hulihan; Paul Lockhart; Audrey Strongosky; Jennifer Kachergus; Donald B Calne; Jon Stoessl; Ryan J Uitti; Ronald F Pfeiffer; Claudia Trenkwalder; Nikolaus Homann; Erwin Ott; Karoline Wenzel; Friedrich Asmus; John Hardy; Zbigniew Wszolek; Thomas Gasser
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

2.  Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.

Authors:  Anna De Rosa; Teresa Pellegrino; Sabina Pappatà; Maria Teresa Pellecchia; Silvio Peluso; Francesco Saccà; Paolo Barone; Alberto Cuocolo; Giuseppe De Michele
Journal:  J Nucl Cardiol       Date:  2015-12-01       Impact factor: 5.952

3.  β-amyloid triggers ALS-associated TDP-43 pathology in AD models.

Authors:  Alexander M Herman; Preeti J Khandelwal; Brenna B Stanczyk; G William Rebeck; Charbel E-H Moussa
Journal:  Brain Res       Date:  2011-03-02       Impact factor: 3.252

4.  Genome-wide association study identifies MAPT locus influencing human plasma tau levels.

Authors:  Jason Chen; Jin-Tai Yu; Kevin Wojta; Hui-Fu Wang; Henrik Zetterberg; Kaj Blennow; Jennifer S Yokoyama; Michael W Weiner; Joel H Kramer; Howard Rosen; Bruce L Miller; Giovanni Coppola; Adam L Boxer
Journal:  Neurology       Date:  2017-01-18       Impact factor: 9.910

5.  Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.

Authors:  R N Alcalay; A Siderowf; R Ottman; E Caccappolo; H Mejia-Santana; M-X Tang; L Rosado; E Louis; D Ruiz; C Waters; S Fahn; L Cote; S Frucht; B Ford; M Orbe-Reilly; B Ross; M Verbitsky; S Kisselev; C Comella; A Colcher; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; M Rezak; K E Novak; J H Friedman; R Pfeiffer; L Marsh; B Hiner; L N Clark; K Marder
Journal:  Neurology       Date:  2010-12-29       Impact factor: 9.910

Review 6.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

Review 7.  The neuropathology of genetic Parkinson's disease.

Authors:  Markos Poulopoulos; Oren A Levy; Roy N Alcalay
Journal:  Mov Disord       Date:  2012-03-26       Impact factor: 10.338

Review 8.  The multiple mechanisms of amyloid deposition: the role of parkin.

Authors:  Maria A Mena; José A Rodríguez-Navarro; Justo García de Yébenes
Journal:  Prion       Date:  2009-01-09       Impact factor: 3.931

9.  The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases.

Authors:  Preeti J Khandelwal; Charbel E-H Moussa
Journal:  Front Psychiatry       Date:  2010-06-03       Impact factor: 4.157

Review 10.  Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models.

Authors:  Marina P Sánchez; Ana M García-Cabrero; Gentzane Sánchez-Elexpuru; Daniel F Burgos; José M Serratosa
Journal:  Int J Mol Sci       Date:  2018-04-05       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.